// Post a message

Replying to:

First Barton Kamen-MGHI prize : Modified COMBAT (Combined Oral Metronomic Biodifferentiating Antiangiogenic Treatment) therapy in poor prognosis pediatric malignant brain tumors

The first Barton Kamen-MGHI Prize has been attributed to Pr Shripad Banavali following the submission of the following abstract. The work will be presented during the 4th Metronomic Meeting that will take place in Milano on the 24th and 25th of June 2014. Dr Shripad D. Banavali is Professor & Head, Dept. of Medical & Pediatric Oncology Vice President (India), Asian Cellular Therapy Organization and Coordinator, TMC-Rural Outreach Program in Mumbai MODIFIED COMBAT (COMBINED ORAL (...)

pre-moderation

This forum is moderated beforehand: your contribution will only appear after being validated by a site administrator.

Any message or comment?
  • (To create paragraphs, you simply leave blank lines.)

Who are you? (optional)